DiaMedica Gets a 15% Lift in Share Price

DiaMedica Gets a 15% Lift in Share Price

DiaMedica_Inc. (TSX-V:DMA) saw some activity in the stock today as it jumped over 15% on above average trading volume finally landing at $0.38 cents at closing. The Company is focused on developing novel treatments for vascular diseases, including stroke and metabolic and kidney dysfunction. Although there was no news out today, the Company did recently announce that the US Patent Office issued a patent for the DiaMedica’s Human Tissue Kallikrein 1 Glycosylation Isoforms, which cover the composition of matter of the Company’s product candidate.

Related posts

Leave a Comment

* Copy This Password *

* Type Or Paste Password Here *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>